Cargando…
NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients
BACKGROUND: Intensive multifactorial treatment aimed at prevention of cardiovascular (CV) disease may reduce left ventricular (LV) echocardiographic abnormalities in diabetic subjects. Plasma N-terminal (NT)-proBNP predicts CV mortality in diabetic patients but the association between P-NT-proBNP an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310741/ https://www.ncbi.nlm.nih.gov/pubmed/22390472 http://dx.doi.org/10.1186/1475-2840-11-19 |
_version_ | 1782227694918828032 |
---|---|
author | Reinhard, Henrik Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rossing, Peter Jacobsen, Peter K |
author_facet | Reinhard, Henrik Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rossing, Peter Jacobsen, Peter K |
author_sort | Reinhard, Henrik |
collection | PubMed |
description | BACKGROUND: Intensive multifactorial treatment aimed at prevention of cardiovascular (CV) disease may reduce left ventricular (LV) echocardiographic abnormalities in diabetic subjects. Plasma N-terminal (NT)-proBNP predicts CV mortality in diabetic patients but the association between P-NT-proBNP and the putative residual abnormalities in such patients are not well described. This study examined echocardiographic measurements of LV hypertrophy, atrial dilatation and LV dysfunction and their relation to P-NT-proBNP levels or subclinical coronary artery disease (CAD) in type 2 diabetic patients with microalbuminuria receiving intensive multifactorial treatment. METHODS: Echocardiography including tissue Doppler imaging and P-NT-proBNP measurements were performed in 200 patients without prior CAD. Patients with P-NT-proBNP > 45.2 ng/L and/or coronary calcium score ≥ 400 were stratified as high risk patients for CAD(n = 133) and examined for significant CAD by myocardial perfusion imaging and/or CT-angiography and/or coronary angiography. RESULTS: LV mass index was 41.2 ± 10.9 g/m(2.7 )and 48 (24%) patients had LV hypertrophy. LA and RA dilatation were found in 54(27%) and 45(23%) patients, respectively, and LV diastolic dysfunction was found in 109(55%) patients. Patients with increased P-NT-proBNP levels did not have more major echocardiographic abnormalities. In 70(53%) of 133 high risk patients significant CAD was demonstrated and patients with LV hypertrophy had increased risk of significant CAD(adjusted odd ratio[CI] was 4.53[1.14-18.06]). CONCLUSION: Among asymptomatic type 2 diabetic patients with microalbuminuria that received intensive multifactorial treatment, P-NT-proBNP levels is not associated with echocardiographic abnormalities. LV diastolic dysfunction was frequently observed, whereas LV hypertrophy was less frequent but associated with significant CAD. |
format | Online Article Text |
id | pubmed-3310741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33107412012-03-23 NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients Reinhard, Henrik Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rossing, Peter Jacobsen, Peter K Cardiovasc Diabetol Original Investigation BACKGROUND: Intensive multifactorial treatment aimed at prevention of cardiovascular (CV) disease may reduce left ventricular (LV) echocardiographic abnormalities in diabetic subjects. Plasma N-terminal (NT)-proBNP predicts CV mortality in diabetic patients but the association between P-NT-proBNP and the putative residual abnormalities in such patients are not well described. This study examined echocardiographic measurements of LV hypertrophy, atrial dilatation and LV dysfunction and their relation to P-NT-proBNP levels or subclinical coronary artery disease (CAD) in type 2 diabetic patients with microalbuminuria receiving intensive multifactorial treatment. METHODS: Echocardiography including tissue Doppler imaging and P-NT-proBNP measurements were performed in 200 patients without prior CAD. Patients with P-NT-proBNP > 45.2 ng/L and/or coronary calcium score ≥ 400 were stratified as high risk patients for CAD(n = 133) and examined for significant CAD by myocardial perfusion imaging and/or CT-angiography and/or coronary angiography. RESULTS: LV mass index was 41.2 ± 10.9 g/m(2.7 )and 48 (24%) patients had LV hypertrophy. LA and RA dilatation were found in 54(27%) and 45(23%) patients, respectively, and LV diastolic dysfunction was found in 109(55%) patients. Patients with increased P-NT-proBNP levels did not have more major echocardiographic abnormalities. In 70(53%) of 133 high risk patients significant CAD was demonstrated and patients with LV hypertrophy had increased risk of significant CAD(adjusted odd ratio[CI] was 4.53[1.14-18.06]). CONCLUSION: Among asymptomatic type 2 diabetic patients with microalbuminuria that received intensive multifactorial treatment, P-NT-proBNP levels is not associated with echocardiographic abnormalities. LV diastolic dysfunction was frequently observed, whereas LV hypertrophy was less frequent but associated with significant CAD. BioMed Central 2012-03-05 /pmc/articles/PMC3310741/ /pubmed/22390472 http://dx.doi.org/10.1186/1475-2840-11-19 Text en Copyright ©2012 Reinhard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Investigation Reinhard, Henrik Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rossing, Peter Jacobsen, Peter K NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
title | NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
title_full | NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
title_fullStr | NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
title_full_unstemmed | NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
title_short | NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
title_sort | nt-probnp, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310741/ https://www.ncbi.nlm.nih.gov/pubmed/22390472 http://dx.doi.org/10.1186/1475-2840-11-19 |
work_keys_str_mv | AT reinhardhenrik ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT hansenpeterr ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT wiinbergniels ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT kjærandreas ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT petersenclausl ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT wintherkaj ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT parvinghanshenrik ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT rossingpeter ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients AT jacobsenpeterk ntprobnpechocardiographicabnormalitiesandsubclinicalcoronaryarterydiseaseinhighrisktype2diabeticpatients |